The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Outlook Therapeutics Inc (NASDAQ: OTLK) closed the day trading at $2.08 up 0.97% from the previous closing price of $2.06. In other words, the price has increased by $0.97 from its previous closing price. On the day, 0.56 million shares were traded. OTLK stock price reached its highest trading level at $2.11 during the session, while it also had its lowest trading level at $2.04.
Ratios:
For a better understanding of OTLK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.72.
On March 27, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $50.
Chardan Capital Markets Upgraded its Neutral to Buy on February 15, 2024, while the target price for the stock was maintained at $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 89135696 and an Enterprise Value of 95583560.
Stock Price History:
The Beta on a monthly basis for OTLK is 0.26, which has changed by -0.745098 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, OTLK has reached a high of $8.70, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 13.60%, while the 200-Day Moving Average is calculated to be -15.55%.
Shares Statistics:
Over the past 3-months, OTLK traded about 755.63K shares per day on average, while over the past 10 days, OTLK traded about 990350 shares per day. A total of 32.91M shares are outstanding, with a floating share count of 26.43M. Insiders hold about 38.31% of the company’s shares, while institutions hold 16.62% stake in the company. Shares short for OTLK as of 1751241600 were 2190871 with a Short Ratio of 2.90, compared to 1748563200 on 3219504. Therefore, it implies a Short% of Shares Outstanding of 2190871 and a Short% of Float of 6.260000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Outlook Therapeutics Inc (OTLK) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.13 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.4 and -$2.33 for the fiscal current year, implying an average EPS of -$1.94. EPS for the following year is -$1.22, with 3.0 analysts recommending between -$0.95 and -$1.55.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $6.51M. There is a high estimate of $8.7M for the next quarter, whereas the lowest estimate is $3M.
Based on 5 analysts’ estimates, the company’s revenue will be $34.93M in the next fiscal year. The high estimate is $50.95M and the low estimate is $17.1M.
